NorthRock Partners LLC Purchases 5,236 Shares of Danaher Corporation $DHR

NorthRock Partners LLC raised its position in Danaher Corporation (NYSE:DHR) by 74.7% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 12,248 shares of the conglomerate’s stock after buying an additional 5,236 shares during the period. NorthRock Partners LLC’s holdings in Danaher were worth $2,420,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Envestnet Portfolio Solutions Inc. boosted its position in shares of Danaher by 4.6% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 78,933 shares of the conglomerate’s stock worth $15,592,000 after purchasing an additional 3,436 shares during the last quarter. Delaney Dennis R boosted its position in shares of Danaher by 2.3% in the 2nd quarter. Delaney Dennis R now owns 25,407 shares of the conglomerate’s stock worth $5,019,000 after purchasing an additional 579 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in shares of Danaher by 9.7% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 21,644 shares of the conglomerate’s stock worth $4,276,000 after purchasing an additional 1,909 shares during the last quarter. Vest Financial LLC boosted its position in shares of Danaher by 39.2% in the 2nd quarter. Vest Financial LLC now owns 7,465 shares of the conglomerate’s stock worth $1,475,000 after purchasing an additional 2,104 shares during the last quarter. Finally, Montrusco Bolton Investments Inc. boosted its position in shares of Danaher by 4.2% in the 2nd quarter. Montrusco Bolton Investments Inc. now owns 1,789,225 shares of the conglomerate’s stock worth $345,804,000 after purchasing an additional 72,680 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on DHR shares. Barclays restated an “overweight” rating and issued a $225.00 price target (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Redburn Partners set a $220.00 price objective on Danaher in a research note on Wednesday. Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective on the stock in a research note on Friday, July 11th. Finally, UBS Group dropped their price objective on Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $244.60.

Danaher Stock Performance

DHR opened at $202.53 on Monday. The business’s 50-day moving average price is $200.66 and its two-hundred day moving average price is $197.07. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41. The company has a market capitalization of $145.02 billion, a price-to-earnings ratio of 43.09, a P/E/G ratio of 2.88 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the business posted $1.72 EPS. The company’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Insider Activity

In other Danaher news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 11.10% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.